Navigation Links
Scientists Tout New Prostate Cancer Test

Oregon scientists say a simple test can identify men at high risk of life-threatening prostate cancer even after a biopsy finds no signs of it//. The key, researchers say, is "PSA density," which compares the size of a man's prostate with his levels of a cancer-related protein called prostate-specific antigen.

Men with the highest PSA densities were much more likely to later be diagnosed with aggressive cancers than men with lower scores in an Oregon study, even though both groups had clean prostate biopsies.

If it survives scientific review, it could help save the lives of men with serious cancers and avoid repeated biopsies in others.

"It's that 1-in-10 men that do have a life-threatening cancer that we wanted to identify," said Dr. Mark Garzotto, an Oregon Health & Science University Cancer Institute researcher, who recently presented the study at a cancer conference in Florida.

Prostate cancer will kill about 27,000 U.S. men this year. Doctors usually check for tumors with a prostate biopsy, which uses needles to gather cells from the gland.

More than a million U.S. men get prostate biopsies each year. The tests find more than 200,000 tumors, meaning many cancer-free men get unneeded biopsies.

Studies estimate that the test fails to find the tumor in 20 percent to 33 percent of men who have one, usually because the needles sample only bits of the gland.

"With less than 1 percent of the prostate sampled, we're trying to get the pathologist to tell us if the guy has cancer or not, which is an impossible task," said Garzotto. So doctors recommend second biopsies a few months after a clean test.

To narrow the need for repeat tests, Garzotto and co-workers studied 511 patients at the Veterans Affairs Medical Center, where he works. All the men had clear initial prostate biopsies. But 112 were later found to have cancer, 52 of them aggressive tumors that can be deadly.

The scientists found that "PSA density, by itself, was the best discriminator between guys in the high-risk group and the guys in the low-risk group," Garzotto said.

By 2 years after their clean biopsy, 23 percent of the men in the high-risk group had aggressive cancer compared with 4 percent of low-risk men, Garzotto said.

At four years, the rate was 36 percent in the high-risk group and 9 percent in the other.

"I feel more comfortable now about recommending repeat biopsies to this (high-risk) group," he said.

Another simple test may identify which men with advanced prostate cancer have the worst outlook, according to a different OHSU study presented at the Florida conference.

Dr. Tomasz Beer found that among men with advanced cancer, those with the highest level of C-reactive protein died significantly sooner than men with lower levels.

C-reactive protein is a sign of inflammation, which doctors increasingly think is "associated with cancer progression and cancer resistance to treatment," Beer said.

Source-Bio-Bio Technology

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:

(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is a ... filling out a survey; in many cases health professionals and patients are working together ... research on the importance of active engagement with patients and members of the public ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... , ... Lori R. Somekh, founder of the Law Office of Somekh ... law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up ... network with elder law attorneys nationwide,” said Somekh. , ElderCounsel was ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX) researchers were ... innovative way to use nonlinear optical imaging to confirm ... drugs. A ... show how researchers from BioPharmX and the Wellman Center ... a suite of imaging techniques in what is called ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017  NDS received FDA 510(k) ... — a medical-grade battery-powered display stand specifically designed for endoscopy environments. ... transform technology into a clinical solution to support the improvement of ... Innovative Design ... Mobile Wireless Solution ...
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
Breaking Medicine Technology: